Gastrointestinal Medication

Antacids

  • Purpose: Subclass of antiulcer drugs used to relieve heartburn/indigestion by reducing stomach acid.
  • Mechanism of action: Neutralize hydrochloric acid (HCl) and reduce pepsin activity. This provides immediate, short-term relief but does not heal underlying disease.
  • Common agents and key points:
    • Sodium bicarbonate (brand: Alpha Seltzer)
    • Side effects: Hypernatremia (excessive sodium), water retention, metabolic alkalosis, and acid rebound (common to all antacids).
    • Calcium carbonate (brand: Tums)
    • Side effects: Acid rebound; hypercalcemia with excessive use.
    • Example caution: In pregnancy, limit to recommended daily maximum (e.g., not exceeding 77 tablets per day in the example).
    • Magnesium hydroxide (Milk of Magnesia)
    • Side effects: Diarrhea.
    • Contraindication: Kidney/renal failure due to risk of magnesium accumulation.
    • Aluminum hydroxide
    • Side effects: Constipation.
  • Acid rebound
    • All antacids can cause acid rebound if used chronically; should not be used long-term without provider guidance.
    • If symptoms persist beyond a short course, seek medical evaluation for chronic GI issues.
  • Nursing considerations (ADPIE framework):
    • Assessment: Evaluate pain/irritation from indigestion; assess renal function, especially with magnesium-containing products; monitor fluid/electrolyte balance.
    • Nursing diagnosis example: Acute pain related to indigestion from spicy foods/alcohol.
    • Plan/Goal: Abdominal pain will decrease after 1–2 weeks of treatment.
    • Interventions:
    • Avoid giving antacids with other medications as they can hinder absorption; space dosing by ext2hoursext{2 hours} before/after other meds (e.g., 8:00 AM med) to prevent interference.
      • Timing: ext2hoursext{2 hours} apart from other meds.
    • Monitor electrolytes and fluid status; assess for electrolyte disturbances.
    • Encourage small amounts of water after taking antacids (e.g., about 2 oz2\ \text{oz}) to ensure the dose reaches the stomach and isn’t left sitting in the mouth.
  • Real-world usage notes:
    • Antacids are commonly used for quick relief and transient symptoms, but chronic GI symptoms require longer-term therapy (e.g., H2 blockers or PPIs).
    • When teaching patients, emphasize that antacids provide symptomatic relief, not cure.

Histamine-2 Receptor Antagonists (H2 Receptor Blockers)

  • Class name and shorthand: H2 receptor antagonists (also called H2 receptor blockers).
  • Mechanism of action: Bind to H2 receptors on gastric parietal cells, blocking histamine-induced acid secretion; reduces gastric acid production.
  • Common drugs (ending in -tid): metadine, famotidine, nizatidine. The prototype discussed is famotidine.
  • Dosing/timing: Take about 30 minutes30\ \text{minutes} before meals to prevent meal-stimulated acid secretion.
  • Uses: Prevention and treatment of gastric and duodenal ulcers; GERD; esophagitis.
  • Pharmacology notes: Pharmacokinetics and pharmacodynamics (absorption, distribution, metabolism, excretion; onset/peak/duration) are listed for PO and IV routes in drug references.
  • Adverse effects vs side effects:
    • Side effects are relatively mild (e.g., headaches, dizziness, fatigue).
    • Adverse effects are more serious and may require discontinuation if they occur.
  • Special considerations:
    • Pregnancy and breastfeeding: Use with caution; adjust as needed.
    • Drug interactions and lab/food interactions may be noted in prescribing information (FRACS acronym referenced for pharmacokinetics).
  • Practical tip: H2 blockers are often chosen for longer-term ulcer/GERD management compared to antacids.

Proton Pump Inhibitors (PPIs)

  • Class name: Proton pump inhibitors (PPIs); all end with -prazol (e.g., pantoprazole, omeprazole, lansoprazole, esomeprazole).
  • Mechanism of action: Inhibit the hydrogen-potassium ATPase (H⁺/K⁺-ATPase) pump in gastric parietal cells, markedly reducing gastric acid production.
  • Comparison to H2 blockers: PPIs reduce acid secretion via a different mechanism and are used for similar indications but are often used for longer-term suppression.
  • Uses: Prevention and treatment of gastric and duodenal ulcers; GERD/esophagitis; other acid-related disorders.
  • Long-term considerations: Prolonged use associated with increased risk of bone fractures due to impaired calcium absorption; monitoring bone health may be warranted with long-term therapy.
  • Common side effects: Headache, dizziness, fatigue; arthralgia (joint pain); not universal to all PPIs but noted as a more notable side effect.
  • Key teaching: Long-term use requires periodic re-evaluation by provider; ensure adequate calcium and vitamin D intake; monitor for fractures in at-risk individuals.

Mucosal Protectants

  • Agent: Sucralfate (mucosal protectant).
  • Mechanism: Does not neutralize acid or inhibit acid secretion; instead forms a viscous barrier/coating over ulcers to protect the mucosa from acid and pepsin.
  • Administration timing: Take about 1 exthourbeforemeals1\ ext{hour before meals} and at bedtime to coat the ulcer before the acid load of meals.
  • Dosing: Typically up to four times daily (before each meal and at bedtime).
  • Side effects: Constipation is a notable adverse effect.
  • Practical note: Important for protective barrier formation; does not address underlying acid secretion.

Prostaglandin Misoprostol

  • Mechanism: Decreases gastric acid secretion and increases protective mucus and bicarbonate production in the stomach.
  • Primary use: Prevention of NSAID-induced gastric ulcers.
  • Additional uses: In OB/GYN settings, misoprostol can be used to induce labor by ripening the cervix (cervical dilation).
  • Black box warning: Do not use in pregnancy as it can cause miscarriage or premature birth if used erroneously; pregnancy testing is recommended before ordering; contraindicated in pregnancy.
  • Clinical notes: Used in patients who require NSAID therapy to prevent ulceration; alternative strategies may be needed in those who are pregnant.

Antiemetics (Drugs for Vomiting)

  • Nonpharmacologic measures:
    • Fluids and electrolytes (e.g., Pedialyte, Gatorade).
    • BRAT diet (Bread, Rice, Applesauce, Toast) and other gentle foods; crackers, toast, bananas; weak teas; flat soda.
  • Over-the-counter (OTC) options:
    • Dimenhydrinate (Dramamine): Antihistamine with antiemetic effects; inhibits vestibular stimulation; useful for motion sickness and N/V.
    • Common side effects: Anticholinergic-like effects (dry mouth, dry eyes, drowsiness, constipation); sedation can impair activities like driving; avoid alcohol.
    • Administration note: Consider taking preemptively for anticipated motion sickness (e.g., before a trip).
  • Prescription options: Antihistamines and anticholinergics (e.g., hydroxyzine, scopolamine).
    • Scopolamine patch: Often placed behind the ear for post-op nausea prevention.
    • Contraindication: Glaucoma (anticholinergic/dilate pupils may worsen intraocular pressure).
  • Dopamine antagonists (antiemetics):
    • Examples: Promethazine (phenothiazine), butyrophenones, benzodiazepines, benzamides.
    • Mechanism: Block dopamine receptors in the chemoreceptor trigger zone (CTZ);
    • Uses: Postoperative N/V, chemotherapy- or radiation-induced N/V.
    • Side effects: Extrapyramidal symptoms (EPS) such as involuntary movements.
  • Serotonin antagonists:
    • Example: Ondansetron (Zofran).
    • Mechanism: Blocks serotonin receptors in CTZ and vagal nerve terminals to prevent vomiting.
    • Uses: N/V due to chemotherapy or postoperative settings.
  • Glucocorticoids:
    • Examples: Dexamethasone, methylprednisolone (often IV).
    • Role: Anti-emetic effects used in combination with other antiemetics for chemotherapy-induced N/V.
  • Cannabinoids:
    • Example: Dronabinol.
    • Uses: N/V related to chemotherapy.
    • Cautions: Contraindicated in individuals with psychiatric disorders due to mood changes, euphoria, drowsiness, nightmares, depersonalization.

Antidiarrheals

  • Causes and context: Diarrhea can result from infections (viral/bacterial travel), toxins, drug reactions, laxative overuse, malabsorption, stress, inflammatory bowel disease, or tumors.
  • Nonpharmacologic management:
    • Fluids and electrolyte solutions (to prevent dehydration).
    • Dietary considerations and identifying triggers (e.g., travel history, foods).
  • Opiate and opioid-related antidiarrheals:
    • Mechanism: Decrease GI motility by acting on opioid receptors in the GI tract.
    • Examples: Diphenoxylate, Diphenoxyn, Loperamide (Imodium).
    • Side effects: CNS depression, physical dependence; caution with longer-term use.
    • Contraindications: Caution with glaucoma if atropine-containing products are used; tapering may be needed in certain cases.
  • Adsorbents/Adsorbents (coat and bind toxins/bacteria):
    • Mechanism: Coat the wall of the GI tract by absorbing or adsorbing bacteria/toxins.
    • Common side effects: Tongue and stool discoloration (noted as standout).
    • Examples: Activated charcoal (emergency overdose use; also used for diarrhea), kaolin, pectin.
  • Salicylate-containing antidiarrheals:
    • Example: Bismuth subsalicylate (Pepto-Bismol).
    • Cautions: Do not give to anyone under age 16 due to risk of Reyes syndrome ( Reyes' syndrome ), a rare but serious brain/liver condition.
    • Note: Salicylates also include aspirin; avoid in children as a precaution.
  • Traveler’s diarrhea context: Prevention/education about safe food and water during travel; hydration and electrolyte balance are crucial.
  • Clinical considerations:
    • Hydration and electrolyte monitoring are important; watch for dehydration and electrolyte imbalances (e.g., hypokalemia).
    • Evaluate dehydration signs: skin turgor, mucous membranes.
    • Not all antidiarrheals are appropriate for infectious causes; if bacterial/viral causes persist, or if fever, blood in stool, or severe symptoms occur, seek medical care.
    • Not recommended for long-term use; underlying cause should be treated.

Laxatives (Constipation Management)

  • Causes of constipation: Inadequate water intake, low fiber diet, processed foods, lack of exercise, pregnancy, neurological issues, medications, bowel obstruction, chronic laxative use, ignoring urge to defecate, inflammatory conditions.
  • Nonpharmacologic management:
    • Increase dietary fiber, water intake, regular exercise, and routine bowel habits.
  • Laxative subclasses (types):
    • Osmotic laxatives
    • Mechanism: Hyperosmolar salts draw water into the intestinal lumen, increasing stool water and bulk to stimulate peristalsis.
    • Effects: Semiformed to watery stool; may be used for bowel prep.
    • Examples: Lactulose, Polyethylene glycol (PEG).
    • Side effects: Fluid/electrolyte imbalance, drowsiness, abdominal cramping, nausea, vomiting, flatulence, diarrhea.
    • Stimulant laxatives
    • Mechanism: Irritate intestinal nerves to increase peristalsis.
    • Examples: Bisacodyl, Senna; often used for bowel prep or to stimulate bowel movement after delivery.
    • Onset: Approximately 8 exthours8\ ext{hours} when taken orally; rectal form acts faster.
    • Side effects: Cramping, nausea, vomiting, diarrhea, fluid/electrolyte imbalance.
    • Bulk-forming laxatives
    • Mechanism: Absorb water to increase stool bulk and promote peristalsis.
    • Examples: Psyllium.
    • Administration: Must take with plenty of water (e.g., mix in a full glass of liquid, drink immediately, and follow with another full glass of fluid) to prevent obstruction.
    • Chloride channel activators
    • Mechanism: Activate chloride channels in the intestinal lining to increase intestinal fluid secretion and motility.
    • Indication: Idiopathic constipation in adults.
    • Example: Lubiprostone.
    • Side effects: Peripheral edema is noted as a standout among their side effects.
    • Emollients (stool softeners)
    • Mechanism: Lower surface tension to allow water into stool, softening it and reducing straining.
    • Example: Docusate sodium.
  • Contraindications and cautions for laxatives:
    • Do not use with undiagnosed abdominal pain (risk of missing a surgical abdomen like appendicitis).
    • Avoid in inflammatory bowel disease (IBD), diverticulitis, bowel obstruction, or certain pregnancy conditions where laxatives could be harmful.
  • Practical clinical notes:
    • Laxatives are not a cure for underlying constipation; assess for underlying causes and avoid long-term reliance.
    • In postpartum or post-surgical patients, laxatives may be used to reduce straining and facilitate bowel movements.

General GI pharmacology connections and practical takeaways

  • Antacids provide rapid, short-term relief; H2 blockers and PPIs are for longer-term management of acid-related disorders (ulcers, GERD).
  • Mucosal protectants offer a barrier rather than changing acid production; useful as adjunct therapy.
  • NSAID users often require protective agents (misoprostol) to prevent ulcers; pregnancy considerations are critical with misoprostol (black box warning).
  • Nonpharmacologic measures (diet, fluids, BRAT, hydration) are foundational and should accompany pharmacologic therapy.
  • Diarrhea management emphasizes hydration, electrolyte balance, and caution against using antidiarrheals when an infection or toxin is suspected.
  • Laxatives vary by mechanism and are chosen based on the type of constipation and patient-specific factors; long-term use is generally discouraged without supervision.
  • The nursing process (ADPIE) is essential across all antiulcer and GI drugs:
    • Assessment of symptoms, renal function, electrolyte balance, hydration status.
    • Diagnosis and care planning with realistic goals.
    • Implementation with attention to timing, drug interactions, and patient education.
    • Evaluation of effect on symptoms and safety, with adjustments as needed.

Quick references and memorization cues

  • Drug name endings as class clues:
    • H2 blockers: endings -tid (e.g., famotidine, nizatidine, metadine).
    • PPIs: endings -prazol (e.g., pantoprazole, omeprazole, lansoprazole, esomeprazole).
  • Sucralfate: take 1 hour before meals and at bedtime (4 times daily).
  • Dimenhydrinate: OTC antiemetic for motion sickness; avoid driving or alcohol due to drowsiness.
  • Ondansetron (Zofran): Serotonin receptor antagonist; strong antiemetic for chemo- and post-op N/V.
  • Dronabinol: Cannabinoid antiemetic; caution in psychiatric disorders due to mood effects.
  • Misoprostol: NSAID ulcer prevention; contraindicated in pregnancy; may induce labor by cervical ripening.
  • Reye’s Syndrome risk with salicylates in children <16 years; avoid bismuth subsalicylate in this population.
  • Watch for electrolyte disturbances with antacids, laxatives, and antidiarrheals; hydration status is critical.

Visual summary (connections to foundational principles)

  • Mechanism diversity reflects multiple levels of gastric protection: acid neutralization (antacids), acid suppression (H2 blockers, PPIs), mucosal protection (sucrose-alcating barriers), and barrier and protective effects (misoprostol, bismuth subsalicylate).
  • The GI tract is highly sensitive to pH and electrolyte balance; therapies can shift acid-base status and mineral absorption (e.g., calcium with PPIs).
  • Pharmacotherapy often requires nonpharmacologic support (diet, fluids, activity) to optimize outcomes and minimize adverse effects.
  • Pediatric and obstetric considerations are critical (Reye’s syndrome, teratogenic risk, labor induction potential).

End of notes